Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EVOK | US
0.17
4.23%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
12/09/2024
4.19
4.09
4.38
4.06
Evoke Pharma Inc. a specialty pharmaceutical company primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists internal medicine specialists primary care physicians and select health care providers. Evoke Pharma Inc. was incorporated in 2007 and is headquartered in Solana Beach California.
View LessStrong P/E, and PEG ratio indicator
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
51.1%1 month
99.1%3 months
101.8%6 months
90.0%0.03
-
1.19
1.88
0.41
-0.36
0.05
-0.10
-
3.12M
3.12M
-
-47.96
-
125.50
-407.60
0.67
0.46
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.95
Range1M
4.46
Range3M
7.64
Rel. volume
0.03
Price X volume
24.34K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.17 | 3.23M | -3.06% | n/a | 8.44% |
SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 1.6 | 3.01M | 11.11% | n/a | 144.16% |
Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.9768 | 2.49M | 0.70% | n/a | 4.26% |
China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 0.66 | 2.09M | 6.62% | n/a | 19.00% |
Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 1.16 | 2.01M | 1.29% | n/a | -104.44% |
Premier Biomedical Inc | BIEI | Drug Manufacturers-Specialty & Generic | 0.0018 | 1.84M | 0.00% | n/a | -22.64% |
Lml Ltd Dematerialised | LMLLF | Drug Manufacturers-Specialty & Generic | 0.0151 | 1.54M | 17.05% | n/a | -98.67% |
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.83 | 1.12M | -12.63% | n/a | -2.89% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.1099 | 0 | n/a | 2.46% | |
Procaps Group S.A. Warrants | PROCW | Drug Manufacturers-Specialty & Generic | 0.0201 | 0 | -32.09% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Forza X1 Inc | FRZA | Recreational Vehicles | 0.215 | 2.95M | -0.78% | n/a | 0.97% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.5 | 860.26K | -5.66% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.25 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.36 | - | Cheaper |
Ent. to Revenue | 0.05 | - | Cheaper |
PE Ratio | 0.03 | 28.13 | Cheaper |
Price to Book | 1.19 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 101.84 | - | Riskier |
Debt to Equity | 1.88 | -0.91 | Expensive |
Debt to Assets | 0.41 | 0.45 | Par |
Market Cap | 3.12M | - | Emerging |